Baijin Life Science Holdings Limited
MNNGF
$0.08
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -169.55% | -169.49% | -225.07% | -224.73% | -122.66% |
| Total Depreciation and Amortization | 454.07% | 453.97% | 74.07% | 73.68% | -2.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 689.07% | 688.42% | -252.32% | -251.93% | 95.13% |
| Change in Net Operating Assets | -633.90% | -633.65% | 345.32% | 345.01% | -32.84% |
| Cash from Operations | -2,141.67% | -2,136.25% | 43.61% | 43.68% | 96.48% |
| Capital Expenditure | -- | -- | -570.59% | -576.47% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.56% | -11.36% | -98.20% | -98.21% | 14,600.00% |
| Cash from Investing | -66.67% | -66.59% | -88.49% | -88.51% | 14,600.00% |
| Total Debt Issued | 454.00% | 454.00% | -39.15% | -39.15% | -- |
| Total Debt Repaid | 13.68% | 13.68% | 87.95% | 87.95% | 97.69% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,193.33% | -2,193.33% | -106.52% | -106.52% | 99.60% |
| Cash from Financing | 4,769.20% | 4,757.81% | 139.94% | 140.03% | -92.28% |
| Foreign Exchange rate Adjustments | -370.24% | -370.18% | -394.01% | -393.51% | -76.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21,984.21% | 21,931.58% | -113.99% | -113.98% | 99.53% |